en fr CN
  • Insights
  • Careers
  • Contact us

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

Contact us
  • Overview
  • Board of Directors & Management team
  • Shareholding structure
  • Stock market data
  • Analyst coverage
  • Financial agenda
  • Press releases
  • Corporate updates
  • Regulated documents
  • Investor contacts
  • About us
    • About iCRO: Oncology Clinical Trial Imaging Services
    • Discover Imaging Lab: AI-Powered Insights
    • Explore the iSee Platform
    • Request a Proposal
    • About eyonis®
    • Lung Cancer (LCS and IPN)
    • Liver Cancer – HCC
  • About us
  • Insights
  • Careers
    • Overview
    • Board of Directors & Management team
    • Shareholding structure
    • Stock market data
    • Analyst coverage
    • Financial agenda
    • Press releases
    • Corporate updates
    • Regulated documents
    • Investor contacts
    • Pharmaceutical Research & Development Executives
    • Biotechnology Executives
    • Clinical Research Organizations
  • Contact us

With eyonis® we are disrupting the management of serious diseases such as lung cancer and liver cancer. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis® is currently under development.

Contact us
  • About eyonis®
  • Lung Cancer (LCS and IPN)
  • Liver Cancer – HCC

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More
Request a Demo
  • About iCRO: Oncology Clinical Trial Imaging Services
  • Discover Imaging Lab: AI-Powered Insights
  • Explore the iSee Platform
  • Request a Proposal
Insights Brochures

Brochures

Keyword
  •  

    eyonis™, end-to-end AI/ML tech-basedCADe/CADx SaMD

    Download eyonis-brochure_A5_VFinal.pdf
  •  

    Introducing Median Imaging Lab

    Download MED002-Imaging-Lab-Fact-Sheet_08i.pdf
  •  

    iCRO capabilities brochure

    Download icro-brochure-1.pdf
  •  

    Tumor Assessment Using RECIST 1.1 Criteria and Alternative Criteria for Immuno-oncology Trials

    Download Tumor_assessment_2021_USA4_7July.pdf
  •  

    Imaging fundamentals: Medical imaging in oncology review

    Download MT-IF-Medical-Imaging-Oncology-Review-v1.3.pdf
  • 1 2 Older Posts

Subscribe to receive email updates on our latest news and events.

Median Technologies collects and process the minimum relevant information to treat your query efficiently. To know more about how we store and process your personal data and about your rights, see our personal data protection policy.

Median Logo
Contact us
  • YouTube
  • Twitter
  • LinkedIn

© 2024 Median Technologies. All rights reserved.

  • Legal notice
  • Data protection policies
  • Corporate policies
  • Conventions conclues et avantages consentis

thinkerdoer